Literature DB >> 19041075

Imaging in rheumatoid arthritis--status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography.

Mikkel Østergaard1, Susanne Juhl Pedersen, Uffe Møller Døhn.   

Abstract

Sensitive and reproducible tools for diagnosis, monitoring of disease activity and damage, and prognostication are essential in the management of patients with rheumatoid arthritis (RA). Conventional radiography (X-ray), the traditional gold standard for imaging in RA, is not able to detect early disease manifestations such as inflammatory changes in the soft tissues (synovitis, tensynovitis, enthesitis etc.) and the earliest stages of bone erosion. In contrast, magnetic resonance imaging (MRI) and ultrasonography (US) allow direct visualization of early inflammatory and destructive joint changes, and have several documented and potential applications in RA patients. This chapter will review key aspects of the current status and recent important advances in imaging in RA, briefly discussing X-ray and computed tomography, and particularly focusing on MRI and US. Suggestions for use in clinical trials and practice are provided.

Entities:  

Mesh:

Year:  2008        PMID: 19041075     DOI: 10.1016/j.berh.2008.09.014

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  38 in total

Review 1.  An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials.

Authors:  Vinod Ravindran; Satish Rachapalli
Journal:  Clin Rheumatol       Date:  2010-08-21       Impact factor: 2.980

2.  Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study.

Authors:  Tamotsu Kamishima; Kazuhide Tanimura; Yuko Aoki; Naoki Kosaka; Masato Shimizu; Megumi Matsuhashi; Jun Fukae; Yujiro Kon; Satoshi Terae; Hiroki Shirato
Journal:  Skeletal Radiol       Date:  2010-05-09       Impact factor: 2.199

3.  Carrier-linked mutual prodrugs of biphenylacetic acid as a promising alternative to bioprecursor fenbufen: design, kinetics, and pharmacological studies.

Authors:  Suneela Dhaneshwar; Manisha Kusurkar; Subhash Bodhankar; Gopal Bihani
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

4.  Musculoskeletal imaging of the inflammatory and degenerative joints: current status and perspectives.

Authors:  Fausto Salaffi; Marina Carotti; Antonio Barile
Journal:  Radiol Med       Date:  2019-02-27       Impact factor: 3.469

5.  Voxel-based mapping of five MR biomarkers in the wrist bone marrow.

Authors:  Louis Marage; Jeremy Lasbleiz; Maxime Fondin; Mathieu Lederlin; Giulio Gambarota; Hervé Saint-Jalmes
Journal:  MAGMA       Date:  2021-03-12       Impact factor: 2.310

Review 6.  Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography.

Authors:  Mikkel Østergaard; Mikael Boesen
Journal:  Radiol Med       Date:  2019-03-18       Impact factor: 3.469

7.  [Imaging in rheumatic diseases. Rheumatoid arthritis and differential diagnostics].

Authors:  T Diekhoff; K-G A Hermann
Journal:  Radiologe       Date:  2012-10       Impact factor: 0.635

8.  Recent advances in imaging in psoriatic arthritis.

Authors:  René Panduro Poggenborg; Lene Terslev; Susanne Juhl Pedersen; Mikkel Ostergaard
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

9.  Radiographic quantifications of joint space narrowing progression by computer-based approach using temporal subtraction in rheumatoid wrist.

Authors:  Shota Ichikawa; Tamotsu Kamishima; Kenneth Sutherland; Takanobu Okubo; Kou Katayama
Journal:  Br J Radiol       Date:  2015-10-20       Impact factor: 3.039

10.  Computer-aided and manual quantifications of MRI synovitis, bone marrow edema-like lesions, erosion and cartilage loss in rheumatoid arthritis of the wrist.

Authors:  Haitao Yang; Julien Rivoire; Michael Hoppe; Waraporn Srikhum; John Imboden; Thomas M Link; Xiaojuan Li
Journal:  Skeletal Radiol       Date:  2014-12-10       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.